Trial intelligence / Profile preview

Intracoronary adenosine during reperfusion in STEMI patients undergoing primary PCI

2007-006671-36Phase 3Completed

Sponsor
Vall d'Hebron University Hospital
Start
Jan 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of adenosine in myocardial infarction (MI) and acute coronary syndrome (ACS), sponsored by Vall d'Hebron University Hospital. Primary endpoint: Infarct size by MRI. Started Jan 2008; status: completed.

02

Drugs

adenosine
03

Conditions

myocardial infarction (MI)acute coronary syndrome (ACS)

Beyond the preview

Go deeper on 2007-006671-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006671-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call